AF/LE Gezuiverd antimens IL-9 Antilichaam[MH9A4]

IL-9 is a 14 kDa cytokine originally named P40 and identified by its proliferative effects on T cell populations. The receptor, which is a heterodimer of the gamma chain portion of the IL-2 receptor and the IL-9R chain, activates Jak/STAT signaling pathways upon binding its ligand. Since the discovery of IL-9, numerous other functions have been observed. It induces Th17 and Treg differentiation in CD4+ T cells, IgE production in B cells, and the differentiation and proliferation of mast cells. IL-9 expression was initially observed in Th2 cells, but has since been found in Th17, eosinophil, and mast cells. Th9 cells, a newly discovered subset of CD4+ T cells, are characterized by the secretion of large amounts of IL-9 and IL-10. Th9 development is induced by stimulation of undifferentiated CD4+ with IL-4 and TGF beta. Th2 cells can also be driven towards a Th9 phenotype in the presence of TGF beta.

IL-9

P15248

Human

Recombinant Human IL-9 protein

Cytokine P; Interleukin; TCGF; IL9; HP40; IL-9; P40; Cytokine P40; Interleukin-9; P40 Cytokine; P40 T-cell and Mast Cell Growth Factor; T-cell Growth Factor P40; TCGF3; TCGFIII

MH9A4

None (AF/LE)

FCM

>98%, Protein A/G purified

≥ 1 mg/mL

66

Sterile PBS, pH 7.2. < 1.0 EU per mg of the antibody as determined by the LAL method.

Ice bag

Store at 4°C valid for 12 months or -20°C valid for long term storage, avoid freeze / thaw cycles. This preparation contains no preservatives, thus it should be handled under aseptic conditions.

https://789.bio/eb/2EUSl0N6

Mouse IgG2b, κ